K. Jürchott, S. Bergmann, U. Stein, W. Walther, M. Janz, I. Manni, G. Piaggio, E. Fietze, M. Dietel, H. Royer (2003)
YB-1 as a Cell Cycle-regulated Transcription Factor Facilitating Cyclin A and Cyclin B1 Gene Expression*Journal of Biological Chemistry, 278
Victor Levenson, Irina Davidovich, Igor Roninson (2000)
Pleiotropic resistance to DNA-interactive drugs is associated with increased expression of genes involved in DNA replication, repair, and stress response.Cancer research, 60 18
T. Ise, G. Nagatani, T. Imamura, Ken Kato, H. Takano, M. Nomoto, H. Izumi, H. Ohmori, Tatsuro Okamoto, T. Ohga, T. Uchiumi, M. Kuwano, K. Kohno (1999)
Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen.Cancer research, 59 2
B. Strauss, M. Haas (1995)
The region 3' to the major transcriptional start site of the MDR1 downstream promoter mediates activation by a subset of mutant P53 proteins.Biochemical and biophysical research communications, 217 1
You‐Fang Zhang, C. Homer, S. Edwards, L. Hananeia, A. Lasham, J. Royds, P. Sheard, A. Braithwaite (2003)
Nuclear localization of Y-box factor YB1 requires wild-type p53Oncogene, 22
R. Mantovani (1999)
The molecular biology of the CCAAT-binding factor NF-Y.Gene, 239 1
Kevin Chen, S. Šale, Thomas Tan, R. Ermoian, B. Sikic (2004)
CCAAT/Enhancer-Binding Protein (cid:1) (Nuclear Factor for Interleukin 6) Transactivates the Human MDR 1 Gene by Interaction with an Inverted CCAAT Box in Human Cancer Cells
U. Scherf, D. Ross, M. Waltham, Lawrence Smith, Jae Lee, L. Tanabe, K. Kohn, W. Reinhold, T. Myers, Darren Andrews, D. Scudiero, M. Eisen, E. Sausville, Y. Pommier, D. Botstein, P. Brown, J. Weinstein (2000)
A gene expression database for the molecular pharmacology of cancerNature Genetics, 24
S. Swamynathan, Balwantkumar Varma, K. Weber, R. Guntaka (2002)
Targeted disruption of one allele of the Y-box protein gene, Chk-YB-1b, in DT40 cells results in major defects in cell cycle.Biochemical and biophysical research communications, 296 2
K. Shibao, H. Takano, Y. Nakayama, K. Okazaki, N. Nagata, H. Izumi, T. Uchiumi, M. Kuwano, K. Kohno, H. Itoh (1999)
Enhanced coexpression of YB‐1 and DNA topoisomerase II α genes in human colorectal carcinomasInternational Journal of Cancer, 83
A. Schinkel, U. Mayer, E. Wagenaar, C. Mol, L. Deemter, J. Smit, M. Valk, A. Voordouw, H. Spits, O. Tellingen, J. Zijlmans, W. Fibbe, P. Borst (1997)
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins.Proceedings of the National Academy of Sciences of the United States of America, 94 8
Zhen Hu, Shengkan Jin, K. Scotto (2000)
Transcriptional Activation of the MDR1 Gene by UV IrradiationThe Journal of Biological Chemistry, 275
R. Sundseth, G. Macdonald, J. Ting, A. King (1997)
DNA elements recognizing NF-Y and Sp1 regulate the human multidrug-resistance gene promoter.Molecular pharmacology, 51 6
H. Izumi, Toshihiro Imamura, G. Nagatani, T. Ise, T. Murakami, H. Uramoto, Takayuki Torigoe, H. Ishiguchi, Y. Yoshida, Minoru Nomoto, Tatsuro Okamoto, Takeshi Uchiumi, M. Kuwano, Keiko Funa, K. Kohno (2001)
Y box-binding protein-1 binds preferentially to single-stranded nucleic acids and exhibits 3'-->5' exonuclease activity.Nucleic acids research, 29 5
H. Yahata, Hiroaki Kobayashi, T. Kamura, S. Amada, T. Hirakawa, K. Kohno, M. Kuwano, H. Nakano (2002)
Increased nuclear localization of transcription factor YB-1 in acquired cisplatin-resistant ovarian cancerJournal of Cancer Research and Clinical Oncology, 128
K. Kohno, S. Sato, T. Uchiumi, H. Takano, S. Kato, M. Kuwano (1990)
Tissue-specific enhancer of the human multidrug-resistance (MDR1) gene.The Journal of biological chemistry, 265 32
K. Takara, Kentaro Takagi, M. Tsujimoto, N. Ohnishi, T. Yokoyama (2003)
Digoxin up-regulates multidrug resistance transporter (MDR1) mRNA and simultaneously down-regulates steroid xenobiotic receptor mRNA.Biochemical and biophysical research communications, 306 1
Manuel Alvarez, K. Paull, Anne Monks, C. Hose, Jong-Seok Lee, John Weinstein, M. Grever, Susan Bates, T. Fojo (1995)
Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen.The Journal of clinical investigation, 95 5
Yoshinao Oda, Akio Sakamoto, Norio Shinohara, T. Ohga, Takeshi Uchiumi, K. Kohno, Masazumi Tsuneyoshi, M. Kuwano, Yukihide Iwamoto (1998)
Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human osteosarcoma.Clinical cancer research : an official journal of the American Association for Cancer Research, 4 9
H. Saji, M. Toi, S. Saji, M. Koike, K. Kohno, M. Kuwano (2003)
Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human breast carcinoma.Cancer letters, 190 2
K. Ueda, D. Clark, Chang-Jie Chen, I. Roninson, M. Gottesman, I. Pastan (1987)
The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation.The Journal of biological chemistry, 262 2
B. Ogretmen, A. Safa (2000)
Identification and characterization of the MDR1 promoter-enhancing factor 1 (MEF1) in the multidrug resistant HL60/VCR human acute myeloid leukemia cell line.Biochemistry, 39 1
Sesha Tekur, André Pawlak, Georges Guellaen, Norman Hecht (1999)
Contrin, the human homologue of a germ-cell Y-box-binding protein: cloning, expression, and chromosomal localization.Journal of andrology, 20 1
N. Combates, R. Rzepka, Y. Chen, D. Cohen (1994)
NF-IL6, a member of the C/EBP family of transcription factors, binds and trans-activates the human MDR1 gene promoter.The Journal of biological chemistry, 269 47
A. Schinkel (1998)
Pharmacological insights from P-glycoprotein knockout mice.International journal of clinical pharmacology and therapeutics, 36 1
Preethello Chaudhary, I. Roninson (1993)
Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs.Journal of the National Cancer Institute, 85 8
U. Stein, K. Jürchott, W. Walther, S. Bergmann, P. Schlag, H. Royer (2001)
Hyperthermia-induced Nuclear Translocation of Transcription Factor YB-1 Leads to Enhanced Expression of Multidrug Resistance-related ABC Transporters*The Journal of Biological Chemistry, 276
S. Kudo, M. Mattei, M. Fukuda (1995)
Characterization of the gene for dbpA, a family member of the nucleic-acid-binding proteins containing a cold-shock domain.European journal of biochemistry, 231 1
N. Kioka, Y. Yamano, T. Komano, K. Ueda (1992)
Heat‐shock responsive elements in the induction of the multidrug resistance gene (MDR1)FEBS Letters, 301
T. Kamura, H. Yahata, S. Amada, S. Ogawa, Takanori Sonoda, H. Kobayashi, Masamune Mitsumoto, K. Kohno, M. Kuwano, H. Nakano (1999)
Is nuclear expression of Y box‐binding protein‐1 a new prognostic factor in ovarian serous adenocarcinoma?Cancer, 85
S. Bates, L. Mickley, Y. Chen, N. Richert, J. Rudick, J. Biedler, A. Fojo (1989)
Expression of a drug resistance gene in human neuroblastoma cell lines: modulation by retinoic acid-induced differentiationMolecular and Cellular Biology, 9
Charles Morrow, Masayuki Nakagawa, M. Goldsmith, Mary Madden, K. Cowan (1994)
Reversible transcriptional activation of mdr1 by sodium butyrate treatment of human colon cancer cells.The Journal of biological chemistry, 269 14
M. Kuwano, T. Uchiumi, H. Hayakawa, M. Ono, M. Wada, H. Izumi, K. Kohno (2003)
The basic and clinical implications of ABC transporters, Y‐box‐binding protein‐1 (YB‐1) and angiogenesis‐related factors in human malignanciesCancer Science, 94
S. Labialle, L. Gayet, E. Marthinet, D. Rigal, L. Baggetto (2002)
Transcriptional regulators of the human multidrug resistance 1 gene: recent views.Biochemical pharmacology, 64 5-6
Gretchen, DarlingtonS, Ira, Pastan, Michael, M., Gottesman (1990)
Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells.The Journal of biological chemistry, 265 1
Miki Miyazaki, K. Kohno, Takeshi Uchiumi, H. Tanimura, Ken-ichi Matsuo, Masaru Nasu, M. Kuwano (1992)
Activation of human multidrug resistance-1 gene promoter in response to heat shock stress.Biochemical and biophysical research communications, 187 2
M. Ladomery, J. Sommerville (1995)
A role for Y-box proteins in cell proliferation.BioEssays : news and reviews in molecular, cellular and developmental biology, 17 1
K. Chin, K. Ueda, I. Pastan, M. Gottesman (1992)
Modulation of activity of the promoter of the human MDR1 gene by Ras and p53.Science, 255 5043
K. Kohno, H. Izumi, T. Uchiumi, Megumi Ashizuka, M. Kuwano (2003)
The pleiotropic functions of the Y-box-binding protein, YB-1.BioEssays : news and reviews in molecular, cellular and developmental biology, 25 7
H. Tanimura, K. Kohno, S. Sato, T. Uchiumi, M. Miyazaki, M. Kobayashi, M. Kuwano (1992)
The human multidrug resistance 1 promoter has an element that responds to serum starvation.Biochemical and biophysical research communications, 183 2
M. Kuo, Zesheng Liu, Yingjie Wei, Y. Lin-Lee, S. Tatebe, G. Mills, H. Unate (2002)
Induction of human MDR1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-κB signalingOncogene, 21
(2001)
Interaction between a base excision repair enzyme and a transcription factor
S. Toh, T. Nakamura, T. Ohga, K. Koike, T. Uchiumi, M. Wada, M. Kuwano, K. Kohno (1998)
Genomic organization of the human Y-box protein (YB-1) gene.Gene, 206 1
Y. Makino, T. Ohga, S. Toh, K. Koike, K. Okumura, M. Wada, M. Kuwano, K. Kohno (1996)
Structural and functional analysis of the human Y-box binding protein (YB-1) gene promoter.Nucleic acids research, 24 10
M. Fromm (2002)
The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans.Advanced drug delivery reviews, 54 10
P. Watkins (1997)
The barrier function of CYP3A4 and P-glycoprotein in the small bowel.Advanced drug delivery reviews, 27 2-3
S. Ambudkar, S. Dey, C. Hrycyna, M. Ramachandra, I. Pastan, M. Gottesman (1999)
Biochemical, cellular, and pharmacological aspects of the multidrug transporter.Annual review of pharmacology and toxicology, 39
P. Gimenez-Bonafe, M. Fedoruk, Tanis Whitmore, M. Akbari, J. Ralph, S. Ettinger, M. Gleave, C. Nelson (2004)
YB‐1 is upregulated during prostate cancer tumor progression and increases P‐glycoprotein activityThe Prostate, 59
K. Shibahara, T. Uchiumi, T. Fukuda, S. Kura, Y. Tominaga, Y. Maehara, K. Kohno, Y. Nakabeppu, T. Tsuzuki, M. Kuwano (2004)
Targeted disruption of one allele of the Y‐box binding protein‐1 (YB‐1) gene in mouse embryonic stem cells and increased sensitivity to cisplatin and mitomycin CCancer Science, 95
A. Wolffe (1994)
Structural and functional properties of the evolutionarily ancient Y‐box family of nucleic acid binding proteinsBioEssays, 16
C. McCoy, D. Smith, M. Cornwell (1995)
12-O-tetradecanoylphorbol-13-acetate activation of the MDR1 promoter is mediated by EGR1Molecular and Cellular Biology, 15
T. Ohga, K. Koike, M. Ono, Y. Makino, Y. Itagaki, M. Tanimoto, M. Kuwano, K. Kohno (1996)
Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light.Cancer research, 56 18
R. Yao, Yian Wang, R. Lubet, M. You (2002)
Differentially expressed genes associated with mouse lung tumor progressionOncogene, 21
A. Bader, K. Felts, N. Jiang, H-W Chang, P. Vogt (2003)
Y box-binding protein 1 induces resistance to oncogenic transformation by the phosphatidylinositol 3-kinase pathwayProceedings of the National Academy of Sciences of the United States of America, 100
P. Graumann, M. Marahiel (1998)
A superfamily of proteins that contain the cold-shock domain.Trends in biochemical sciences, 23 8
K. Asakuno, K. Kohno, T. Uchiumi, T. Kubo, S. Sato, M. Isono, M. Kuwano (1994)
Involvement of a DNA binding protein, MDR-NF1/YB-1, in human MDR1 gene expression by actinomycin D.Biochemical and biophysical research communications, 199 3
N. Combates, Kwon Po, R. Rzepka, D. Cohen (1997)
Involvement of the transcription factor NF-IL6 in phorbol ester induction of P-glycoprotein in U937 cells.Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 8 2
Shengkan Jin, K. Scotto (1998)
Transcriptional Regulation of the MDR1 Gene by Histone Acetyltransferase and Deacetylase Is Mediated by NF-YMolecular and Cellular Biology, 18
Xiao Huang, K. Ushijima, K. Komai, Yumi Takemoto, Shigenobu Motoshima, T. Kamura, K. Kohno (2004)
Co-expression of Y box-binding protein-1 and P-glycoprotein as a prognostic marker for survival in epithelial ovarian cancer.Gynecologic oncology, 93 2
Y. Oda, Y. Ohishi, Tsuyoshi Saito, E. Hinoshita, T. Uchiumi, N. Kinukawa, Y. Iwamoto, K. Kohno, M. Kuwano, M. Tsuneyoshi (2003)
Nuclear expression of Y‐box‐binding protein‐1 correlates with P‐glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcomaThe Journal of Pathology, 199
K. Kohno, Shin-ichi Sato, H. Takano, Ken-ichi Matsuo, M. Kuwano (1989)
The direct activation of human multidrug resistance gene (MDR1) by anticancer agents.Biochemical and biophysical research communications, 165 3
S. Chuang, S. Doong, M. Lin, A. Cheng (1997)
Tax of the human T-lymphotropic virus type I transactivates promoter of the MDR-1 gene.Biochemical and biophysical research communications, 238 2
Yasuhiro Ito, H. Yoshida, K. Shibahara, T. Uruno, K. Nakano, Y. Takamura, A. Miya, Kaoru Kobayashi, T. Yokozawa, F. Matsuzuka, Takeshi Uchimi, M. Kuwano, E. Miyoshi, N. Matsuura, K. Kuma, A. Miyauchi (2003)
Y‐box binding protein expression in thyroid neoplasms: Its linkage with anaplastic transformationPathology International, 53
T. Ohga, T. Uchiumi, Y. Makino, K. Koike, M. Wada, M. Kuwano, K. Kohno (1998)
Direct Involvement of the Y-box Binding Protein YB-1 in Genotoxic Stress-induced Activation of the Human Multidrug Resistance 1 Gene*The Journal of Biological Chemistry, 273
Hideki Tanaka, N. Ohshima, M. Ikenoya, Kin-ichi Komori, F. Katoh, H. Hidaka (2003)
HMN-176, an active metabolite of the synthetic antitumor agent HMN-214, restores chemosensitivity to multidrug-resistant cells by targeting the transcription factor NF-Y.Cancer research, 63 20
M. Janz, N. Harbeck, P. Dettmar, U. Berger, A. Schmidt, K. Jürchott, M. Schmitt, H. Royer (2002)
Y‐box factor YB‐1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI‐1International Journal of Cancer, 97
M. Cornwell, D. Smith (1993)
SP1 activates the MDR1 promoter through one of two distinct G-rich regions that modulate promoter activity.The Journal of biological chemistry, 268 26
H. Uramoto, H. Izumi, T. Ise, M. Tada, T. Uchiumi, M. Kuwano, K. Yasumoto, K. Funa, K. Kohno (2002)
p73 Interacts with c-Myc to Regulate Y-box-binding Protein-1 Expression*The Journal of Biological Chemistry, 277
J. Thottassery, G. Zambetti, K. Arimori, E. Schuetz, J. Schuetz (1997)
p53-dependent regulation of MDR1 gene expression causes selective resistance to chemotherapeutic agents.Proceedings of the National Academy of Sciences of the United States of America, 94 20
Xiaoling Zhong, A. Safa (2004)
RNA Helicase A in the MEF1 Transcription Factor Complex Up-regulates the MDR1 Gene in Multidrug-resistant Cancer Cells*Journal of Biological Chemistry, 279
N. Vilaboa, A. Galán, A. Troyano, E. Blas, P. Aller (2000)
Regulation of Multidrug Resistance 1 (MDR1)/P-glycoprotein Gene Expression and Activity by Heat-Shock Transcription Factor 1 (HSF1)*The Journal of Biological Chemistry, 275
S. Madden, Donna Cook, J. Morris, A. Gashler, V. Sukhatme, F. Rauscher (1991)
Transcriptional repression mediated by the WT1 Wilms tumor gene product.Science, 253 5027
Tatsuro Okamoto, H. Izumi, Toshihiro Imamura, H. Takano, T. Ise, T. Uchiumi, M. Kuwano, K. Kohno (2000)
Direct interaction of p53 with the Y-box binding protein, YB-1: a mechanism for regulation of human gene expressionOncogene, 19
T. Yamada, A. Takaoka, Y. Naishiro, R. Hayashi, K. Maruyama, C. Maesawa, Atsushi Ochiai, S. Hirohashi (2000)
Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis.Cancer research, 60 17
R. Bargou, K. Jürchott, C. Wagener, S. Bergmann, S. Metzner, K. Bommert, M. Mapara, K. Winzer, M. Dietel, B. Dörken, H. Royer (1997)
Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expressionNature Medicine, 3
M. Bentires-Alj, V. Barbu, M. Fillet, A. Chariot, B. Relic, N. Jacobs, J. Gielen, M. Merville, V. Bours (2003)
NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cellsOncogene, 22
Takeshi Uchiumi, K. Kohno, H. Tanimura, Ken-ichi Matsuo, Seiji Sato, Yuzo Uchida, M. Kuwano (1993)
Enhanced expression of the human multidrug resistance 1 gene in response to UV light irradiation.Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 4 3
K. Koike, T. Uchiumi, T. Ohga, S. Toh, M. Wada, K. Kohno, M. Kuwano (1997)
Nuclear translocation of the Y‐box binding protein by ultraviolet irradiationFEBS Letters, 417
M. Goldsmith, J. Gudas, E. Schneider, K. Cowan (1995)
Wild Type p53 Stimulates Expression from the Human Multidrug Resistance Promoter in a p53-negative Cell Line (*)The Journal of Biological Chemistry, 270
Dina Marenstein, Maria Ocampo, M. Chan, Alvin Altamirano, A. Basu, R. Boorstein, R. Cunningham, G. Teebor (2001)
Stimulation of Human Endonuclease III by Y Box-binding Protein 1 (DNA-binding Protein B)The Journal of Biological Chemistry, 276
R. Johnson, T. Ince, K. Scotto (2001)
Transcriptional Repression by p53 through Direct Binding to a Novel DNA Element* 210The Journal of Biological Chemistry, 276
Molecular Cancer Therapeutics – Unpaywall
Published: Nov 1, 2004
Access the full text.
Sign up today, get DeepDyve free for 14 days.